FDA Approves New Inhaler for COPD – WebMD

The drug, called Tudorza Pressair (aclidinium bromide), is a dry powder inhaler. It improves airflow by relaxing the muscles around the large airways of the lungs. Patients use it twice a day. Tudorza Pressair is approved for the long-term …

Leave a Reply

Your email address will not be published. Required fields are marked *